GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Alar Pharmaceuticals 6785.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

76.50

+3.66%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 2.8m

FY2017FY2025

Net income

−TWD 79.7m

FY2017FY2025

Free cash flow

−TWD 173.9m

FY2017FY2025

Shareholders' equity

TWD 2.40bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueTWD 2.8mTWD 5.8mTWD 469.3mTWD 800,000—TWD 600,000—TWD 500,000TWD 600,000
Research and developmentTWD 156.5mTWD 57.3mTWD 56.7mTWD 34.2mTWD 81.9mTWD 160.3mTWD 53.1mTWD 63.3mTWD 16.3m
Operating income−TWD 167.8m−TWD 67.9mTWD 391.2m−TWD 32.5m−TWD 64.2m−TWD 142.8m−TWD 61.4m−TWD 70.9m−TWD 20.7m
Net income−TWD 79.7mTWD 18.2mTWD 382.6m−TWD 19.9m−TWD 64.2m−TWD 142.8m−TWD 68.0m−TWD 53.8m−TWD 20.7m
Diluted earnings per share-1.190.266.67-0.35-1.13-2.86-1.94-1.96-3.44

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsTWD 2.49bnTWD 2.56bnTWD 973.2mTWD 522.6mTWD 539.9mTWD 604.0m—TWD 273.4mTWD 22.4m
Cash and short-term investments——TWD 896.0mTWD 486.2mTWD 519.1mTWD 583.6mTWD 128.5mTWD 253.0mTWD 2.8m
Total liabilitiesTWD 84.3mTWD 64.3mTWD 76.1mTWD 8.1mTWD 5.5mTWD 5.4mTWD 145,000TWD 14.3mTWD 2.2m
Debt—TWD 604,000TWD 1.4mTWD 2.7mTWD 949,000TWD 1.5mTWD 2.4m——
Shareholders' equityTWD 2.40bnTWD 2.49bnTWD 897.1mTWD 514.5mTWD 534.4mTWD 598.6m—TWD 259.2mTWD 20.3m
Shares outstanding67m71m57m57m57m50m35m27m6m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−TWD 171.0m−TWD 75.3mTWD 403.6m−TWD 32.9m−TWD 63.5m−TWD 141.9m−TWD 69.4m−TWD 41.6m−TWD 17.2m
Capital spending−TWD 2.9m−TWD 1.2m−TWD 6.3m−TWD 1.1m−TWD 1.6m−TWD 385,000——−TWD 129.1m
Free cash flow−TWD 173.9m−TWD 76.5mTWD 397.2m−TWD 34.1m−TWD 65.0m−TWD 142.3m−TWD 69.4m−TWD 41.6m−TWD 146.2m
Dividends paid−TWD 16.7m−TWD 100.2m———————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 1.3mTWD 250,000TWD 1.5m—TWD 1.3m——TWD 5.8m
Operating incomeTWD 5.8m−TWD 64.7m−TWD 56.2m−TWD 56.1m−TWD 11.9m−TWD 43.6m−TWD 19.2m−TWD 9.7m
Net incomeTWD 15.6m−TWD 35.2m−TWD 25.4m−TWD 27.1m−TWD 25.1m−TWD 2.1mTWD 24.9m−TWD 15.2m
Diluted earnings per share0.23-0.53-0.38-0.41-0.38-0.030.35-0.21
Cash from operations−TWD 25.0m−TWD 26.0m−TWD 83.0m−TWD 50.0mTWD 7.0m−TWD 44.0mTWD 17.0m−TWD 11.0m
Capital spending——−TWD 1.0m————−TWD 1.0m
Free cash flow——−TWD 84.0m————−TWD 12.0m
Total assetsTWD 2.45bnTWD 2.48bnTWD 2.49bnTWD 2.52bnTWD 2.52bnTWD 2.56bnTWD 2.56bnTWD 2.52bn
Shareholders' equityTWD 2.38bnTWD 2.37bnTWD 2.40bnTWD 2.42bnTWD 2.45bnTWD 2.49bnTWD 2.49bnTWD 2.47bn

Financial ratios

Data as of 28 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-6095.1%-1168.0%83.4%-4064.5%—-23794.0%
Net margin-2894.4%312.4%81.5%-2483.9%—-23799.5%
Return on equity-3.3%0.7%42.6%-3.9%-12.0%-23.9%
Return on assets-3.2%0.7%39.3%-3.8%-11.9%-23.6%
Free cash flow yield—-1.1%7.2%-0.6%——
Revenue growth-52.7%-98.8%58559.0%———
Earnings growth-538.5%-95.3%-2025.5%-69.1%-55.0%—
Current ratio31.59x44.33x12.08x92.66x118.67x143.31x
Debt to equity——0.00x0.00x0.00x0.00x
Equity ratio96.6%97.5%92.2%98.4%99.0%99.1%
Interest coverage-2071.58x-2516.44x6209.03x-1478.00x-3057.62x-4326.18x
R&D as a share of sales5685.1%985.7%12.1%4272.8%—26721.3%
Buybacks as a share of market value—-23.5%-0.7%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue51.0%35.6%—
Operating income72.8%3.3%—
Net income58.9%-11.0%—

Valuation history

At each fiscal year end

FY2025FY2023FY2022FY2021FY2020
Price to earnings-254.830.8-328.4-41.7-17.1
Price to sales—25.1———

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 10 Jun 2025.

FY2025FY2024
Paid in the year0.251.50

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.